Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « ISSN » - entrée « 1435-1463 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
14346621 < 1435-1463 < 1435-4373  Facettes :

List of bibliographic references indexed by 1435-1463

Number of relevant bibliographic references: 82.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
002400 (1994) S. Enochs [États-Unis] ; T. Sarna [Pologne] ; L. Zecca [Italie] ; A. Riley [Royaume-Uni] ; M. Swartz [États-Unis]The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis
002401 (1994) K. Ossowska [Pologne]The role of excitatory amino acids in experimental models of Parkinson's disease
002405 (1994) R. Rodríguez-Puertas [Espagne] ; A. Pazos [Espagne] ; J. Zarranz [Espagne] ; J. Pascual [Espagne]Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer's disease: An autoradiographic study using3H-hemicholinium-3
002431 (1994) Ch. Müller [Autriche] ; S. Wenger [Autriche] ; L. Fertl [Autriche] ; E. Auff [Autriche]Initiation of visual-guided random saccades and remembered saccades in parkinsonian patients with severe motor-fluctuations
002435 (1994) C. Mytilineou [États-Unis] ; P. Werner [États-Unis] ; S. Molinari [États-Unis] ; A. Di Rocco [États-Unis] ; G. Cohen [États-Unis] ; D. Yahr [États-Unis]Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease
002438 (1994) P. Vieregge [Allemagne]Genetic factors in the etiology of idiopathic Parkinson's disease
002450 (1994) A. Espino [Espagne] ; S. Ambrosio [Espagne] ; R. Bartrons [Espagne] ; G. Bendahan [Espagne] ; M. Calopa [Espagne]Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+
002499 (1993) H. Baas [Allemagne] ; K. Stecker [Allemagne] ; A. Fischer [Allemagne]Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease
002501 (1993) M. Pinter [Autriche] ; J. Helscher [Autriche]Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease
002506 (1993) T. Klockgether [Allemagne] ; P. Jacobsen [Danemark] ; -A. Löschmann [Allemagne] ; L. Turski [Allemagne]The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist
002512 (1993) K. Vrecko [Autriche] ; D. Birkmayer [Autriche] ; J. Krainz [Autriche]Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adeninedinucleotide (NADH)
002513 (1993) J. Helscher [Autriche] ; M. Pinter [Autriche]Speed and power of higher cerebral functions in parkinsonian patients
002516 (1993) M. Wu [Taïwan] ; C. Chiu [Taïwan] ; M. Wang [Taïwan] ; C. Chen [Taïwan]Risk factors on the occurrence of response fluctuations and dyskinesias in Parkinson's disease
002522 (1993) E. Fertl [Autriche] ; A. Doppelbauer [Autriche] ; E. Auff [Autriche]Physical activity and sports in patients suffering from Parkinson's disease in comparison with healthy seniors
002532 (1993) M. Palmer [États-Unis] ; T. Dekosky [États-Unis]Monoamine neurons in aging and Alzheimer's disease
002533 (1993) H. Tohgi [Japon] ; T. Abe [Japon] ; S. Takahashi [Japon] ; J. Takahashi [Japon] ; Y. Nozaki [Japon] ; M. Ueno [Japon] ; T. Kikuchi [Japon]Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes
002537 (1993) R. Volpi [Italie] ; P. Caffarra [Italie] ; A. Scaglioni [Italie] ; A. Saginario [Italie] ; D. Maestri [Italie] ; S. Vourna [Italie] ; P. Vescovi [Italie] ; P. Chiodera [Italie] ; V. Coiro [Italie]Lack of ACTH/cortisol and GH responses to intravenously-infused substance P in Parkinson's disease
002540 (1993) S. Markus [Royaume-Uni] ; M. Tomkins [Royaume-Uni] ; M. Stern [Royaume-Uni]Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters
002543 (1993) T. Greenamyre [États-Unis]Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease
002544 (1993) J. Kornhuber [Allemagne] ; M. Weller [Allemagne] ; P. Riederer [Allemagne]Glutamate receptor antagonists for neuroleptic malignant syndrome and akitetic hyperthermic Parkinsonian crisis
002549 (1993) H. Heinonen [Finlande] ; M. Savij Rvi [Finlande] ; M. Kotila [Finlande] ; A. Hajba [Finlande] ; M. Scheinin [Finlande]Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1435-1463" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1435-1463" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1435-1463
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024